Maurizio Chiriva-Internati is the founder of Kiromic Biopharma. Kiromic Biopharma has raised $55M in total funding. Latest round: IPO.
Maurizio Chiriva-Internati co-founded Kiromic Biopharma, Inc. in 2012, a biotechnology company focused on advancing immuno-oncology therapies. He led the company through a successful initial public offering in October 2020, raising approximately $15 million.
Full founder directory · Investor directory · Company funding database · Fundraising library